- Home
- INTT vs HLVX Comparison
INTT vs HLVX Comparison
Compare INTT & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTT
- HLVX
- Stock Information
- Founded
- INTT 1981
- HLVX 2020
- Country
- INTT United States
- HLVX United States
- Employees
- INTT N/A
- HLVX N/A
- Industry
- INTT Semiconductors
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- INTT Technology
- HLVX Health Care
- Exchange
- INTT Nasdaq
- HLVX Nasdaq
- Market Cap
- INTT 89.8M
- HLVX 104.3M
- IPO Year
- INTT 1997
- HLVX 2022
- Fundamental
- Price
- INTT $7.59
- HLVX $2.09
- Analyst Decision
- INTT Strong Buy
- HLVX Hold
- Analyst Count
- INTT 2
- HLVX 1
- Target Price
- INTT $12.00
- HLVX $2.00
- AVG Volume (30 Days)
- INTT 46.3K
- HLVX 930.2K
- Earning Date
- INTT 10-31-2025
- HLVX 11-06-2025
- Dividend Yield
- INTT N/A
- HLVX N/A
- EPS Growth
- INTT N/A
- HLVX N/A
- EPS
- INTT N/A
- HLVX N/A
- Revenue
- INTT $121,642,000.00
- HLVX N/A
- Revenue This Year
- INTT N/A
- HLVX N/A
- Revenue Next Year
- INTT $10.38
- HLVX N/A
- P/E Ratio
- INTT N/A
- HLVX N/A
- Revenue Growth
- INTT N/A
- HLVX N/A
- 52 Week Low
- INTT $5.24
- HLVX $1.34
- 52 Week High
- INTT $9.77
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- INTT 54.70
- HLVX 51.29
- Support Level
- INTT $7.08
- HLVX $2.07
- Resistance Level
- INTT $7.35
- HLVX $2.11
- Average True Range (ATR)
- INTT 0.23
- HLVX 0.02
- MACD
- INTT -0.35
- HLVX -0.00
- Stochastic Oscillator
- INTT 96.32
- HLVX 50.00
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.